Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
Clinical trial NCT05546879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05546879
- Sponsor
- University Hospital, Grenoble
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2026-03-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.